Hong Kong Pharma Digital Technology Limited (HKPD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Hong Kong Pharma Digital ...

NASDAQ: HKPD · Real-Time Price · USD
1.21
0.17 (16.35%)
At close: Sep 05, 2025, 3:59 PM
1.16
-4.13%
After-hours: Sep 05, 2025, 07:57 PM EDT

Hong Kong Pharma Digital Technology Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023
Revenue
20.31M 16.69M 12.56M
Cost of Revenue
17.9M 13.13M 9.82M
Gross Profit
2.42M 3.56M 2.74M
Operating Income
132.04K 1.61M 1.04M
Interest Income
1.74K 474.00 219.00
Pretax Income
36.11K 1.53M 1.02M
Net Income
-27.06K 1.33M 998.2K
Selling & General & Admin
2.22M 1.89M 1.76M
Research & Development
n/a n/a n/a
Other Expenses
67.26K 60.95K -62.95K
Operating Expenses
2.28M 1.95M 1.7M
Interest Expense
97.67K 82.77K 23.24K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
20.18M 15.08M 11.51M
Income Tax Expense
63.17K 196.25K 22.57K
Shares Outstanding (Basic)
n/a n/a 11M
Shares Outstanding (Diluted)
n/a n/a 11M
EPS (Basic)
n/a n/a 0.09
EPS (Diluted)
n/a n/a 0.09
EBITDA
1.21M 2.53M 1.76M
EBIT
133.78K 1.61M 1.04M
Depreciation & Amortization
1.07M 925.58K 714.59K